This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
JAMA Network Open
jamanetworkopen.com
did:plc:u24xx3ogdvglyk6xbhyesvm4
In pembrolizumab-treated advanced #CervicalCancer, cisplatin and carboplatin provided equivalent survival. Bevacizumab addition improved early overall survival but the benefit decreased over time. #Oncology
ja.ma/44t10n4
2026-07-17T10:30:01.964Z